| Social Determinants of Health |
1 |
1 |
| Genomic Medicine |
0 |
0.98 |
| Biologic Therapy |
0 |
0.73 |
| Skin Cancer |
0 |
0.68 |
| Breast Cancer |
0 |
0.67 |
| Colorectal Cancer |
0 |
0.64 |
| Lung Cancer |
0 |
0.63 |
| Advanced and Metastatic Breast Cancer |
0 |
0.61 |
| Cancer |
0 |
0.97 |
| Medicare |
0 |
0.47 |
| DNA Sequencing |
0 |
0.99 |
| Noncommunicable Diseases |
0 |
0.44 |
| Targeted Cancer Therapy |
0 |
0.42 |
| Metastasis |
0 |
0.41 |
| Small Cell Lung Cancer |
0 |
0.36 |
| Biomarker |
0 |
0.26 |
| Revenue and Practice Management |
0 |
0.2 |
| Electronic Health Record (EHR) and Healthcare Technology |
0 |
0.17 |
| Insurance |
0 |
0.15 |
| Medicaid |
0 |
0.15 |
| Melanoma |
0 |
0.15 |
| Breast |
0 |
0.11 |
| Precision Medicine |
0 |
0.11 |
| Biopsy |
0 |
0.04 |
| Electronic Medical Record |
0 |
0.04 |
| Health Equity |
0 |
0.04 |
| Lung |
0 |
0.04 |
| Racial and Ethnic Disparity |
0 |
0.04 |